Sasha Stephen is a Dermatology physician affiliated with Brigham and Women's Hospital. OpenAlex indexes 13 publications with 509 citations (h-index 6); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
75 Francis St
Boston, MA 021156110
Telephone
617-732-5500Provider last certified this registry record 19 Dec 2022.
Clinical trials
- Impact of Physical and Occupational Therapy in New BMT Patients
Sponsor: UNC Lineberger Comprehensive Cancer Center
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
29.2%Azole Antifungal16.4%Ketoconazole100%Part D≥45 patientsLincosamide Antibacterial5%Clindamycin Phosphate100%Part D≥11 patients+ 3 more classes in this area
Sensory organs
23%Corticosteroid23%Clobetasol Propionate50%Hydrocortisone38%Betamethasone Diprop Augmented11%Part D≥44 patientsDermatology
21.3%Corticosteroid11.1%Triamcinolone Acetonide100%Part D≥52 patientsInterleukin-4 Receptor alpha Antagonist10.2%Dupixent Syringe72%Dupixent Pen28%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Increasing incidence of cutaneous T-cell lymphoma among children and young adults in the United States, 1997-2019: A national poplation-based study using the National Childhood Cancer Registry
Journal of the American Academy of Dermatology
2026 - The effect of levonorgestrel‐releasing intrauterine devices on acne vulgaris: A prospective cohort study
International Journal of Gynecology & Obstetrics
2026 - Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A Multicenter Retrospective Study of 377 Adult Patients from the United States
Journal of Investigative Dermatology
2018
Similar KOLs
Other experts from the same institution or the same specialty.
Paul Ridker, MD
Brigham and Women's Hospital
Scott Solomon, MD
Brigham and Women's Hospital
Dennis Selkoe, MD
Brigham and Women's Hospital
Marc Pfeffer, MD
Brigham and Women's Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”